These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 66839)

  • 1. A review of d-tubocurarine in clinical usage.
    Perotti GS
    AANA J; 1977 Apr; 45(2):182-6. PubMed ID: 66839
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypokalemia during anesthesia: the effects of d-tubocurarine, gallamine, succinylcholine, thiopental, and halothane with or without respiratory alkalosis.
    Wong KC; Wetstone D; Martin WE; Cheney F; Wyte SR
    Anesth Analg; 1973; 52(4):522-8. PubMed ID: 4268669
    [No Abstract]   [Full Text] [Related]  

  • 3. [Histamine release due to ganglion blocking agent and muscle relaxants from rat mast cells].
    Tanaka H
    Hokkaido Igaku Zasshi; 1985 Mar; 60(2):273-81. PubMed ID: 2581878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine liberation in surgical patients following administration of neuromuscular blocking drugs.
    Ertama PM
    Ann Clin Res; 1982 Feb; 14(1):15-26. PubMed ID: 6182834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of ketamine with d-tubocurarine, pancuronium, and succinylcholine in man.
    Johnston RR; Miller RD; Way WL
    Anesth Analg; 1974; 53(4):496-501. PubMed ID: 4858244
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of mediator release by volatile anesthetics.
    Hirshman CA
    Minerva Anestesiol; 1988 Apr; 54(4):171-3. PubMed ID: 2463499
    [No Abstract]   [Full Text] [Related]  

  • 7. The potentiation of depolarizing muscle-relaxants by propanidid. An investigation in animals.
    Musinu C; Tagliamonte A; Gessa GL
    Anaesthesia; 1968 Apr; 23(2):211-4. PubMed ID: 5647884
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interaction of suxamethonium and D-tubocurarine with respect to hyperkalemia. Analysis of phase II of dual block].
    Castañeda Casado J; Palomo Delgado M; Almazán Duro A
    Rev Esp Anestesiol Reanim; 1978 Jul; 25(4):329-37. PubMed ID: 694166
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of succinylcholine and d-tubocurarine on oxygen consumption.
    Muldoon SM; Theye RA
    Anesthesiology; 1969 Nov; 31(5):437-42. PubMed ID: 5345294
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
    Glisson SN; Sanchez MM; El-Etr AA; Lim RA
    Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine release following intravenous injection of d-tubocurarine.
    Salem MR; Kim Y; el Etr AA
    Anesthesiology; 1968; 29(2):380-2. PubMed ID: 4170617
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in the tubocurarine antagonism of the activation of muscle spindle afferents by siccinylcholine, acetylcholine and nicotine.
    Smith CM; Albuquerque EX
    J Pharmacol Exp Ther; 1967 Jun; 156(3):573-84. PubMed ID: 4226371
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibition of histamine liberation with atropine sulfate following administration of d-tubocurarine].
    Kubo K
    Anaesthesist; 1985 Oct; 34(10):502-7. PubMed ID: 2416236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of anti-histaminic drugs on histamine liberation induced by d-tubocurarine].
    Tashiro C; Jordan WS
    Masui; 1976 Aug; 25(8):768-75. PubMed ID: 61289
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of human recombinant IL-1 on d-tubocurarine-induced histamine release from isolated rat peritoneal mast cells.
    Otsuka H; Abe K; Oka M
    Agents Actions; 1992 Jul; 36(3-4):178-82. PubMed ID: 1382370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of muscle relaxants.
    Katz LE
    AANA J; 1981 Feb; 49(1):35-42. PubMed ID: 7234311
    [No Abstract]   [Full Text] [Related]  

  • 17. Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine.
    Basta SJ; Savarese JJ; Ali HH; Moss J; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():105S-106S. PubMed ID: 6190488
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiac glycosides and drugs used in anesthesia and resuscitation].
    Nicolas F
    Minerva Anestesiol; 1972 Mar; 38(3):127-90. PubMed ID: 4671393
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of d-tubocurarine-induced histamine release by halothane.
    Kettlekamp NS; Austin DR; Downes H; Cheek DB; Hirshman CA
    Anesthesiology; 1987 May; 66(5):666-9. PubMed ID: 2437835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case against the use of d-tubocurarine in operant studies of the cardiovascular system.
    Lober CW
    Percept Mot Skills; 1974 Jun; 38(3):1287-92. PubMed ID: 4138044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.